Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to Erin L Schenk

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Schenk, Erin

One or more keywords matched the following properties of Schenk, Erin

Property	Value
keywords	Lung Cancer

One or more keywords matched the following items that are connected to Schenk, Erin

Item Type	Name
Concept	Lung Neoplasms
Academic Article	Local and systemic immunity predict survival in patients with pulmonary sarcomatoid carcinoma.
Academic Article	New Developments in Neoadjuvant Therapy for Lung Cancer.
Academic Article	A Changing of the Guard: Immune Checkpoint Inhibitors With and Without Chemotherapy as First Line Treatment for Metastatic Non-small Cell Lung Cancer.
Academic Article	Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer.
Academic Article	Tumor-intrinsic response to IFN? shapes the tumor microenvironment and anti-PD-1 response in NSCLC.
Academic Article	A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 Study.
Academic Article	Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non-Small-Cell Lung Cancer.
Academic Article	CDK4/6 inhibition alone and in combination for non-small cell lung cancer.
Academic Article	Cancer Cell-Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung Adenocarcinoma.
Academic Article	Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing.
Academic Article	Blood-Based Biomarkers for Predicting Immunotherapy Benefit in Lung Cancer.
Academic Article	2020 Innovation-Based Optimism for Lung Cancer Outcomes.
Academic Article	Adjunctive interferon-alpha-2c in stage IIIB/IV small-cell lung cancer: a phase III trial.
Academic Article	CD73 and Adenosine Receptor Signaling as a Potential Therapeutic Target in EGFR-Mutated NSCLC.
Academic Article	Cancer Cell-Specific Major Histocompatibility Complex II Expression as a Determinant of the Immune Infiltrate Organization and Function in the NSCLC Tumor Microenvironment.
Academic Article	Optimal Therapy for Advanced Non-Small Cell Lung Cancer Without Driver Alterations.
Academic Article	SPF: A spatial and functional data analytic approach to cell imaging data.
Academic Article	Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.2.
Academic Article	Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.2.
Academic Article	Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunity.
Academic Article	CNS Downstaging: An Emerging Treatment Paradigm for Extensive Brain Metastases in Oncogene-Addicted Lung Cancer.
Academic Article	Narrative review: immunotherapy in anaplastic lymphoma kinase (ALK)+ lung cancer-current status and future directions.
Academic Article	Re-ORIENT-ing antitumor immunity in EGFR-mutant non-small cell lung cancer: are antiangiogenics the key?
Academic Article	An advanced NSCLC patient with ALK-RNF144A and HIP1-ALK fusions treated with ALK-TKI combination therapy: a case report.
Grant	Tumor Microenvironment Determinants of TKI Response in Oncogene-Driven Lung Cancer

Search Criteria

Lung cancer